Detalhe da pesquisa
1.
Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring.
J Infect Dis
; 229(4): 1158-1165, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38099506
2.
Risk factors for and outcomes of ring expulsions with a 1-year contraceptive vaginal system.
Am J Obstet Gynecol
; 230(5): 548.e1-548.e8, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295968
3.
Development and verification of mechanistic vaginal absorption and metabolism model to predict systemic exposure after vaginal ring and gel application.
Br J Clin Pharmacol
; 90(6): 1428-1449, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450818
4.
Acceptability of the Dapivirine Vaginal Ring and Oral Truvada Among African Users in Late-Stage of Pregnancy.
AIDS Behav
; 28(3): 963-973, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932492
5.
Women's motivations for participating in the dapivirine vaginal ring open label extension study.
AIDS Care
; 36(3): 326-342, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734338
6.
Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex.
AIDS Care
; 36(1): 80-86, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37066990
7.
Self-reported removal and expulsion of the dapivirine vaginal ring: qualitative reports from female ring users and their male partners in the Ring Study (IPM 027).
BMC Public Health
; 24(1): 1458, 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38822304
8.
Long-term continuations rate of ring pessary use for symptomatic pelvic organ prolapse.
Arch Gynecol Obstet
; 309(5): 2203-2209, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189963
9.
Clinical Presentation, Treatment Response, and Virology Outcomes of Women Who Seroconverted in the Dapivirine Vaginal Ring Trials-The Ring Study and DREAM.
Clin Infect Dis
; 76(3): 389-397, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36189636
10.
Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction.
Clin Infect Dis
; 76(6): 996-1002, 2023 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36345569
11.
ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study.
Am J Obstet Gynecol
; 228(6): 716.e1-716.e12, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870409
12.
Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial.
AIDS Behav
; 27(3): 1030-1043, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066762
13.
Efficacy and Action of the Dapivirine Vaginal Ring as Understood by Women Participating in an Open Label Extension Study.
AIDS Behav
; 27(1): 75-81, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672549
14.
Acceptability and Use of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) During Breastfeeding in South Africa, Malawi, Zimbabwe, and Uganda.
AIDS Behav
; 27(12): 4114-4123, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432541
15.
Adolescent Girls and Young Women's Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis.
AIDS Behav
; 27(12): 3941-3951, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37392268
16.
The impact of combined contraceptive vaginal ring on vaginal environment: an observational, longitudinal study.
Eur J Contracept Reprod Health Care
; 28(4): 234-237, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37417287
17.
[THE USE OF VAGINAL RINGS FOR THE TREATMENT OF GENITAL ORGAN PROLAPSE].
Harefuah
; 162(2): 92-97, 2023 Feb.
Artigo
em Hebraico
| MEDLINE | ID: mdl-36916078
18.
Impact of Dapivirine and Placebo Vaginal Rings on the Microbiota of Adolescent, Lactating, and Postmenopausal Females.
J Infect Dis
; 225(12): 2208-2218, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865071
19.
Assessment of risk compensation following use of the dapivirine vaginal ring in southwestern Uganda.
Sex Transm Infect
; 98(1): 32-37, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33542153
20.
Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe.
AIDS Behav
; 26(12): 3848-3861, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674885